AURX
Price
$1.32
Change
-$0.18 (-12.00%)
Updated
Jun 25 closing price
Capitalization
61.81M
VRAX
Price
$0.79
Change
+$0.02 (+2.60%)
Updated
Jun 27 closing price
Capitalization
3.39M
Interact to see
Advertisement

AURX vs VRAX

Header iconAURX vs VRAX Comparison
Open Charts AURX vs VRAXBanner chart's image
Nuo Therapeutics
Price$1.32
Change-$0.18 (-12.00%)
Volume$51.84K
Capitalization61.81M
Virax Biolabs Group
Price$0.79
Change+$0.02 (+2.60%)
Volume$39.15K
Capitalization3.39M
AURX vs VRAX Comparison Chart in %
Loading...
AURX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AURX vs. VRAX commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AURX is a Hold and VRAX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (AURX: $1.32 vs. VRAX: $0.79)
Brand notoriety: AURX and VRAX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AURX: 617% vs. VRAX: 68%
Market capitalization -- AURX: $61.81M vs. VRAX: $3.39M
AURX [@Biotechnology] is valued at $61.81M. VRAX’s [@Biotechnology] market capitalization is $3.39M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AURX’s FA Score shows that 0 FA rating(s) are green whileVRAX’s FA Score has 1 green FA rating(s).

  • AURX’s FA Score: 0 green, 5 red.
  • VRAX’s FA Score: 1 green, 4 red.
According to our system of comparison, both AURX and VRAX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AURX’s TA Score shows that 3 TA indicator(s) are bullish while VRAX’s TA Score has 4 bullish TA indicator(s).

  • AURX’s TA Score: 3 bullish, 4 bearish.
  • VRAX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, VRAX is a better buy in the short-term than AURX.

Price Growth

AURX (@Biotechnology) experienced а -12.00% price change this week, while VRAX (@Biotechnology) price change was -1.13% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AURX($61.8M) has a higher market cap than VRAX($3.39M). AURX YTD gains are higher at: -5.714 vs. VRAX (-65.109). AURX has higher annual earnings (EBITDA): -2.39M vs. VRAX (-6.43M). VRAX has more cash in the bank: 7.29M vs. AURX (55.7K). AURX has less debt than VRAX: AURX (148K) vs VRAX (380K). AURX has higher revenues than VRAX: AURX (1.62M) vs VRAX (84.9K).
AURXVRAXAURX / VRAX
Capitalization61.8M3.39M1,825%
EBITDA-2.39M-6.43M37%
Gain YTD-5.714-65.1099%
P/E RatioN/AN/A-
Revenue1.62M84.9K1,902%
Total Cash55.7K7.29M1%
Total Debt148K380K39%
FUNDAMENTALS RATINGS
AURX: Fundamental Ratings
AURX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
PROFIT vs RISK RATING
1..100
74
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AURXVRAX
RSI
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
72%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 3 days ago
85%
Declines
ODDS (%)
N/A
Bearish Trend 13 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
85%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AURX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ABLZF59.552.92
+5.16%
ABB Ltd.
RTBBF22.00N/A
N/A
RATHBONES GROUP PLC.
KLYCY9.31N/A
N/A
Kunlun Energy Co., Ltd.
SAVNF0.05N/A
N/A
SAVANNAH RESOURCES PLC
HYTLF0.03N/A
-1.33%
HYTERRA LTD.

AURX and

Correlation & Price change

A.I.dvisor tells us that AURX and ALZN have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AURX and ALZN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AURX
1D Price
Change %
AURX100%
N/A
ALZN - AURX
27%
Poorly correlated
-0.68%
VRAX - AURX
27%
Poorly correlated
+1.95%
YECO - AURX
26%
Poorly correlated
N/A
QSI - AURX
23%
Poorly correlated
-3.47%
NCNA - AURX
23%
Poorly correlated
N/A
More

VRAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRAX has been loosely correlated with SNGX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if VRAX jumps, then SNGX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRAX
1D Price
Change %
VRAX100%
+1.95%
SNGX - VRAX
52%
Loosely correlated
-0.73%
ALZN - VRAX
43%
Loosely correlated
-0.68%
GOVX - VRAX
38%
Loosely correlated
+1.04%
BVNKF - VRAX
27%
Poorly correlated
N/A
AURX - VRAX
27%
Poorly correlated
N/A
More